AMOLI ORGANICS/UMEDICA LABORATORIES

Amoli Organics, established 25 years ago in India, is a leading pharmaceutical manufacturer and exporter of APIs and intermediates, operating two manufacturing sites approved by WHO GMP, USFDA, EDQM/EU GMP, PMDA (Japan), TGA (Australia), ANVISA (Brazil) and COFEPRIS (Mexico). The company offers APIs across anti-inflammatory, anti-hyperlipidemic, antidepressant, antidiabetic, anticonvulsant, antifungal and vitamin categories, with key products including Diclofenac salts, Atorvastatin Calcium and Rosuvastatin. Its 12,000 sq ft R&D center develops in-house process technology for APIs, and Amoli has a strong presence in more than 85 countries, including India.